Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Watts

Showing results (591-600 of 610) with videos related to

Pageof 61
Sort By:
American Journal of Human Genetics|March 29, 2002
PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD studyAnita L DeStefano, Mark F Lew, Lawrence I Golbe, et al.
JAMA|November 17, 2001
Complete genomic screen in Parkinson disease: evidence for multiple genesW K Scott, M A Nance, R L Watts, et al.
Human Molecular Genetics|October 23, 2003
Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson diseaseYi-Ju Li, Sofia A Oliveira, Puting Xu, et al.
JAMA|November 17, 2001
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson diseaseE R Martin, W K Scott, M A Nance, et al.
Transplantation and Cellular Therapy|December 9, 2022
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN TrialsSaurabh Chhabra, Natalie Callander, Nicole L Watts, et al.
Archives of Neurology|June 14, 2006
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD studyMei Sun, Jeanne C Latourelle, G Frederick Wooten, et al.
American Journal of Human Genetics|March 5, 2002
Age at onset in two common neurodegenerative diseases is genetically controlledYi-Ju Li, William K Scott, Dale J Hedges, et al.
JNCI Cancer Spectrum|September 19, 2025
Pre-diagnostic circulating bile acid concentrations and liver cancer risk: a nested case-control analysis of 12 cohortsCody Z Watling, Jessica L Petrick, Barry I Graubard, et al.
Journal of the National Cancer Institute|July 10, 2026
Circulating pre-diagnostic metabolites and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a population-based study of 12 cohortsCody Z Watling, Eleanor L Watts, Erikka Loftfield, et al.
Nature Medicine|June 4, 2024
Proteomic analysis of cardiorespiratory fitness for prediction of mortality and multisystem disease risksAndrew S Perry, Eric Farber-Eger, Tomas Gonzales, et al.
Pageof 61

Showing results (591-600 of 610) with videos related to

Sort By:
Pageof 61
American Journal of Human Genetics|March 29, 2002
PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD studyAnita L DeStefano, Mark F Lew, Lawrence I Golbe, et al.
JAMA|November 17, 2001
Complete genomic screen in Parkinson disease: evidence for multiple genesW K Scott, M A Nance, R L Watts, et al.
Human Molecular Genetics|October 23, 2003
Glutathione S-transferase omega-1 modifies age-at-onset of Alzheimer disease and Parkinson diseaseYi-Ju Li, Sofia A Oliveira, Puting Xu, et al.
JAMA|November 17, 2001
Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson diseaseE R Martin, W K Scott, M A Nance, et al.
Transplantation and Cellular Therapy|December 9, 2022
Stem Cell Mobilization Yields with Daratumumab- and Lenalidomide-Containing Quadruplet Induction Therapy in Newly Diagnosed Multiple Myeloma: Findings from the MASTER and GRIFFIN TrialsSaurabh Chhabra, Natalie Callander, Nicole L Watts, et al.
Archives of Neurology|June 14, 2006
Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD studyMei Sun, Jeanne C Latourelle, G Frederick Wooten, et al.
American Journal of Human Genetics|March 5, 2002
Age at onset in two common neurodegenerative diseases is genetically controlledYi-Ju Li, William K Scott, Dale J Hedges, et al.
JNCI Cancer Spectrum|September 19, 2025
Pre-diagnostic circulating bile acid concentrations and liver cancer risk: a nested case-control analysis of 12 cohortsCody Z Watling, Jessica L Petrick, Barry I Graubard, et al.
Journal of the National Cancer Institute|July 10, 2026
Circulating pre-diagnostic metabolites and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a population-based study of 12 cohortsCody Z Watling, Eleanor L Watts, Erikka Loftfield, et al.
Nature Medicine|June 4, 2024
Proteomic analysis of cardiorespiratory fitness for prediction of mortality and multisystem disease risksAndrew S Perry, Eric Farber-Eger, Tomas Gonzales, et al.
Pageof 61